• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
ZHANG Hui, YANG Xiao. Meta-analysis on early predictive value of urinary TIMP-2 and IGFBP-7 product for acute kidney injury in cardiac postoperative patients[J]. Journal of Clinical Nephrology, 2019, 19(5): 340-346. DOI: 10.3969/j.issn.1671-2390.2019.05.008
Citation: ZHANG Hui, YANG Xiao. Meta-analysis on early predictive value of urinary TIMP-2 and IGFBP-7 product for acute kidney injury in cardiac postoperative patients[J]. Journal of Clinical Nephrology, 2019, 19(5): 340-346. DOI: 10.3969/j.issn.1671-2390.2019.05.008
shu

Meta-analysis on early predictive value of urinary TIMP-2 and IGFBP-7 product for acute kidney injury in cardiac postoperative patients

  • Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

More Information
  • Received Date: October 23, 2018
  • Available Online: May 11, 2023
  • Published Date: May 27, 2019
    Graphical Abstract
    • Abstract
  • Objective To assess the early predictive value of urinary TIMP-2 and IGFBP-7 product for postoperative acute kidney injury in cardiac postoperative patients. Methods EMBASE, Pubmed, Cochrane, Web of Science, CNKI, Sinomed and Wanfang database were searched. The limited time is from February 1,2014 to February 1,2018. A total of 138 articles related to "prediction of postoperative acute kidney injury in patients with heart-related surgery" were retrieved and 10 articles were screened out.The required data were extracted. QUADAS-2 quality evaluation criteria were used to evaluate the literature.Meta-DiSc 1.4 software was used for data analysis and publication bias was tested by Stata 12.0. Subgroup analysis, meta-regression, and sensitivity analysis were adopted to identify the sources of heterogeneity. Results Ten articles were screened out eventually and they related to a total number of 659 cases (AKI occurring, 202 cases; and no AKI occurrence, 457 cases). Heterogeneity test showed Spearman correlation coefficient of 0.067 (P=0.855), suggesting that the threshold effect of heterogeneity was not obvious. With meta-analysis it was found that, the pooled diagnostic odds ratio I2 was <25%, suggesting that there was no heterogeneity in the non-threshold effect between studies. The combined effect of urine TIMP-2 and IGFBP-7 product for early predictionof AKI in postoperative patients with cardiac surgery showed sensitivity of 0.72 (95% CI 0.66~0.78), specificity of 0.72 (95% CI 0.68~0.76), diagnostic odds ratio of 8.12 (95% CI 5.46~12.08), pooled AUC=0.8021, indicating thaturinary TIMP-2 and IGFBP-7 producthad good predictive value for early acute kidney injury in patients after cardiac surgery.The publication bias was not obvious. Subgroup analysis shows that the sample size might be the source of heterogeneity, the meta-regression results did not reveal significant heterogeneity, and sensitivity analysis showed that this method did not have poor robustness. Conclusions Urine TIMP-2 and GFBP-7 product has important clinical value in early predicting acute renal injury in patients after cardiac surgery, but it still needs further large-scale clinical studies to confirm.
    • FullText(HTML)
    • References (35)
  • [1]
    Kuitunen A,Vento A,Suojaranta-Ylinen R,et al.Acute renal failure after cardiac surgery:evaluation of the RIFLE classification[J]. Ann Thorac Surg,2006,81(2):542-546.
    [2]
    Conlaon PJ,Stafford-Smith M,White WD et al.Acute renal failure following cardiac surgery[J]. Nephrol Dial Transplant,1999,14(5):1158-1162.
    [3]
    Machado MN,Nakazone MA,Maia LN. Prognostic value of acute kidney injury after cardiac surgery according to kidney disease:improving global outcomes definition and staging (KDIGO) criteria[J]. PLoS One,2014,9(5):e98028.
    [4]
    Chertow GM,Levy EM,Hammermeister KE,et al.Independent association between acute renal failure and mortality following cardiac surgery[J]. Am J Med,1998,104(4):343-348.
    [5]
    Reents W,Hilker M,Börgermann J,et al.Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients[J]. Ann Thorac Surg,2014,98(1):9-15.
    [6]
    Coca SG,Yusuf B,Shlipak MG,et al.Long-term risk of mortality and other adverse outcomes after acute kidney injury:a systematic review and meta-analysis[J]. Am J Kidney Dis,2009,53(6):961-973.
    [7]
    Hsu C-y,Chertow GM,McCulloch CE,et al.Nonrecovery of kidney function and death after acute on chronic renal failure[J]. Clin J Am Soc Nephrol 2009,4(5):891-898.
    [8]
    Haase M,Bellomo R,Matalanis G,et al.A comparison of the RIFLE and acute kidney injury network classifications for cardiac surgery-associated acute kidney injury:A prospective cohort study[J]. J Thorac Cardiovasc Surg,2009,138(6):1370-1376.
    [9]
    Pilarczyk K,Edayadiyil-Dudasova M,Wendt D,et al.Urinary[TIMP-2] *[IGFBP-7] for early prediction of acute kidney injury after coronary artery bypass surgery[J]. Ann intensive care,2015,5(1):50.
    [10]
    Gist KM,Goldstein SL,Wrona J,et al.Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery[J]. Pediatr Nephrol,2017,32(9):1611-1619.
    [11]
    Hoste EAJ,Clermont G,Kersten A,et al.RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients:a cohort analysis[J]. Crit care,2006,10(3):R73.
    [12]
    Mehta RL,Kellum JA,Shah SV,et al.Acute kidney injury network:report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care,2007,11(2):R31.
    [13]
    Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract,2012,120(4):c179-c184.
    [14]
    Wang Y,Zou Z,Jin J,et al.Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery[J]. BMC nephrol,2017,18(1):177.
    [15]
    Finge T,Bertran S,Roger C,et al.Interest of urinary[TIMP-2] x[IGFBP-7] for predicting the occurrence of acute kidney injury after cardiac surgery:a gray zone approach[J]. Anesth Analg,2017,125(3):762-769.
    [16]
    Meersch M,Schmidt C,Van Aken H,et al.Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery[J]. PLoS One,2014,9(10):e110865.
    [17]
    Mayer T,Bolliger D,Scholz M,et al.Urine biomarkers of tubular renal cell damage for the prediction of acute kidney injury after cardiac surgery-a pilot study[J]. J Cardiothorac Vasc Anesth,2017,31(6):2072-2079.
    [18]
    Zarbock A,Meersch M,Schmidt C,et al.Urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery[J]. Crit Care,2014,18(Suppl 1):P381.
    [19]
    Wetz AJ,Richardt EM,Wand S,et al.Quantification of urinary TIMP-2 and IGFBP-7:an adequate diagnostic test to predict acute kidney injury after cardiac surgery?[J]. Crit care,2015,19(1):3.
    [20]
    Dusse F,Edayadiyil-Dudásova M,Thielmann M,et al.Erratum to:‘Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers’[J]. BMC Anesthesiol,2016,16(1):82.
    [21]
    Zaouter C,Priem F,Leroux L,et al.New markers for early detection of acute kidney injury after transcatheter aortic valve implantation[J]. Anaesth Criti Care Pain Med,2018,37(4):319-326.
    [22]
    Bellomo R,Auriemma S,Fabbri A,et al.The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI)[J]. Int J Artif Organs,2008,31(2):166-178..
    [23]
    Herget-Rosenthal S,Poppen D,Husing J,et al.Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis[J]. Clin Chem,2004,50(3):552-558.
    [24]
    Bell M,Larsson A,Venge P,et al.Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury[J]. Dis Markers,2015,2015:158658.
    [25]
    Beitland S,Waldum-Grevbo BE,Nakstad ER,et al.Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest[J]. Crit Care,2016,20(1):314.
    [26]
    王伟伟, 潘鑫, 唐晓倩, 等.血清心型脂肪酸结合蛋白在急性肾损伤诊断中的临床意义[J].临床肾脏病杂志,2018,18(4):229-233.
    [27]
    Baker WL,Anglade MW,Baker EL,et al.Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications:a meta-analysis[J]. Eur J Cardiothorac Surg,2009,35(3):521-527.
    [28]
    Clerico A,Galli C,Fortunato A,et al.Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury:a review of the laboratory characteristics and clinical evidences[J]. Clin Chem Lab Med,2012,50(9):1505-1517.
    [29]
    谢瑜, 沈颖, 罗惠民, 等.慢性肾脏病心肌损害与心型脂肪酸结合蛋白及心肌钙蛋白的相关性分析[J].昆明理工大学学报,2015,40(6):89-95.
    [30]
    Imai A,Komatsu S,Ohara T,et al.Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography[J]. Atherosclerosis,2011,218(2):350-355.
    [31]
    Huber W,Eising V,Beitz A,et al.916:prognostic value of nephrocheck (urinary[TIMP-2] *[IGFBP7]) in a general icu a prospective study[J]. Crit Care Med,2014,42(12):A1580-A1581.
    [32]
    Honore PM,Nguyen HB,Gong M,et al.Urinary tissue Inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis[J]. Crit Care Med,2016,44(10):1851-1860.
    [33]
    Kashani K,Al-Khafaji A,Ardiles T,et al.Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury[J]. Crit care,2013,17(1):R25.
    [34]
    Jia HM,Huang LF,Zheng Y,et al.Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury:A systematic review and meta-analysis[J]. Nephrology (Carlton),2017,22(11):831-837.
    [35]
    Koyner JL,Shaw AD,Chawla LS,et al.Tissue inhibitor metalioproteinase-2(TIMP-2)IGF-Binding Protein-7(IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI[J]. J Am Soc Nephrol,2015,26(7):1747-1754.
    • Related Articles

  • Related Articles

    [1]Li Yu-ye, Zhu Qing-nan, Sun Yu, Wen Qing-si, Shi Yan, Yan Ze-wen, Lin Hong-li, Wang Da-peng, He Jun-jun. Pregnancy outcomes in patients with chronic kidney disease：a Meta analysis[J]. Journal of Clinical Nephrology, 2024, 24(11): 906-921. DOI: 10.3969/j.issn.1671-2390.2024.11.005
    [2]Chen Hong-yue, Fan Ni-na, Geng Wei, Wang Bai-hui, Zou Rong. Efficacy of Fangji Huangqi Decoction for chronic kidney disease: a Meta-analysis[J]. Journal of Clinical Nephrology, 2024, 24(7): 557-566. DOI: 10.3969/j.issn.1671-2390.2024.07.005
    [3]Wuerguli ·Abudukadier, Ma Qin, Wang Shun, Wang Shi-han. Effect of hyperchloremia on acute kidney injury in critically ill patients: a Meta-analysis[J]. Journal of Clinical Nephrology, 2023, 23(7): 548-556. DOI: 10.3969/j.issn.1671-2390.2023.07.004
    [4]Luo Pu-chang, Chen Hong-bo. Network Meta-analysis of efficacy of integrated traditional Chinese and western medicine for acute kidney injury[J]. Journal of Clinical Nephrology, 2022, 22(12): 1006-1015. DOI: 10.3969/j.issn.1671-2390.2022.12.007
    [5]Liu Wu, Wang Cheng-gang, Su Wen-min, Jiang He, Li Zi-teng, Zhang Zhao, Jiang Xiao-yu. A meta-analysis of the efficacy of rituximab in the treatment of refractory nephrotic syndrome[J]. Journal of Clinical Nephrology, 2021, 21(4): 307-313. DOI: 10.3969/j.issn.1671-2390.y20-132
    [6]Mao Jie-yu, Fu Rong, Yin Gui-lan, Yuan Lin-li. Meta-analysis of the effect of eating during dialysis on the incidence of hypotension and hypoglycemia during dialysis[J]. Journal of Clinical Nephrology, 2021, 21(4): 302-306. DOI: 10.3969/j.issn.1671-2390.m20-135
    [7]WANG Rui, HU Hong-tao, HU Shuang, HE Hong, SHUI Hua. Roxadustat for the treatment of anemia in patients with chronic kidney disease: a Meta-analysis[J]. Journal of Clinical Nephrology, 2019, 19(12): 871-876. DOI: 10.3969/j.issn.1671-2390.2019.12.002
    [8]LUO Lei, DENG Jin, ZHANG Chun-hui, XIE Huan, XIE Hong-ping. A Meta-analysis of the treatment of uremic peripheral neuropathy with levocarnitine combined with hemodialysis[J]. Journal of Clinical Nephrology, 2018, 18(9): 546-550. DOI: 10.3969/j.issn.1671-2390.2018.09.007
    [9]LV Yuan, XU Cheng-yun. A Meta-analysis of Cinacalcet in the treatment of dialysis patients with secondary hyperparathyroidism[J]. Journal of Clinical Nephrology, 2018, 18(8): 460-465. DOI: 10.3969/j.issn.1671-2390.2018.08.003
    [10]YANG Ling. Meta analysis of efficiency and safety of sevelamer in the treatment of hyperphosphatemia in patients with maintenance hemodialysis[J]. Journal of Clinical Nephrology, 2018, 18(2): 82-86. DOI: 10.3969/j.issn.1671-2390.2018.02.004

  • Cited by

    Periodical cited type(7)

    1. 杨孟，郭佳，孟祥林. 重度烧伤患者入院时尿[TIMP-2]×[IGFBP7]水平与早期肾损伤的关系. 西部医学. 2024(02): 228-231 .
    2. 姜冰玉，王世琪，宋苗苗，王晓敏. 尿[TIMP-2]×[IGFBP7]对老年急性冠脉综合征患者急性肾损伤发病和预后的预测价值. 中国老年学杂志. 2024(14): 3410-3413 .
    3. 杨云飞，李晓岚，王爱田，赵华灵，付珊珊，张建军，梁静涛. 尿液TIMP-2、IGFBP-7在老年急性肾损伤患者中的临床诊断预后价值研究. 国际检验医学杂志. 2023(01): 49-53 .
    4. 陈琦，丁秀和，李薇，李迎芝. TIMP-2·IGFBP-7对成例肾病综合征急性肾损伤发生发展的预测价值. 系统医学. 2023(09): 21-24 .
    5. 顾帅帅，朱琳，金艳盛，丁岚，范茂虓. 糖尿病肾病患者尿液基质金属蛋白酶组织抑制剂2、胰岛素样生长因子结合蛋白7的水平及其临床意义. 实用临床医药杂志. 2022(13): 35-40 .
    6. 汪翊，冯杰，谢席胜，宋彬. 急性胰腺炎合并急性肾损伤：诊断、危险因素分层和早期生物标志物. 中国中西医结合肾病杂志. 2022(07): 646-649 .
    7. 刘景卓，张欣桐，李盼，马德胜，马莉. 细胞周期阻滞与脓毒症诱导的急性肾损伤研究进展. 中华重症医学电子杂志(网络版). 2021(02): 164-168 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (329) PDF downloads (373) Cited by(8)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles
    Links

    Website Copyright © Wuhan Medical and Health Association Joint Office Editorial Department of Journal of Clinical Nephrology   备案号：鄂ICP备13011742号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return